BackRegulus Therapeutics Overview

Regulus Therapeutics Research & Development

Research & Development expenses for RGLS.

Quarterly R&D Expenses

$6.82M
↑ 12.9% YoY

As of Mar 31, 2025

Annual R&D Expenses (TTM)

$36.15M
↑ 62.74% YoY

Trailing 12 months ending Mar 31, 2025

Average R&D Expenses (Comparison Companies)

Research & Development History

Research & Development Comparison

Annual Research & Development Growth Rate (%)

Annual Research & Development Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin